Best British Dividend Stocks
Discover investment opportunities in Best British Dividend Stocks using our Smart AI Filter.
AI is processing your request...
AI is analyzing your request
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best British Dividend Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best British Dividend Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Best British Dividend Stocks using our Smart AI Filter.
10 stocks found for "Best British Dividend Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
---|---|---|---|---|---|---|
0.35 Risk measure | ±26.5% Price volatility | 8.9 Valuation | 4.20% Annual yield | |||
0.71 Risk measure | ±23.6% Price volatility | 8.2 Valuation | 6.21% Annual yield | |||
0.45 Risk measure | ±20.5% Price volatility | 12.7 Valuation | 3.02% Annual yield | |||
0.46 Risk measure | ±18.0% Price volatility | 32.0 Valuation | 2.08% Annual yield | |||
0.68 Risk measure | ±20.5% Price volatility | 43.6 Valuation | 11.87% Annual yield | |||
0.40 Risk measure | ±17.8% Price volatility | 17.5 Valuation | 3.04% Annual yield | |||
0.66 Risk measure | ±23.0% Price volatility | 8.5 Valuation | 7.73% Annual yield | |||
1.00 Risk measure | ±30.8% Price volatility | 11.6 Valuation | 4.98% Annual yield | |||
0.28 Risk measure | ±21.2% Price volatility | 10.3 Valuation | 6.19% Annual yield | |||
0.48 Risk measure | ±25.5% Price volatility | 14.8 Valuation | 2.84% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
AstraZeneca has become the latest pharma firm to announce a multi-billion investment in the U.S. The Anglo-Swedish biotech firm has committed to spend $50 billion by 2030.
Read moreGSK stock falls as an FDA panel votes against its Blenrep combo, casting doubt on U.S. approval hopes.
Read moreBP agrees to sell its U.S. wind business to LS Power after a competitive bid, targeting $3-$4 billion in 2025 divestments.
Read moreMichael Roberts, the CEO of HSBC Bank plc and CEO of Corporate and Institutional Banking, discusses how clients are navigating tariffs and the wider global macro environment.
Read moreThe Zacks Internet - Content industry participants like RELX and DHX are benefiting from expanding mobile, digital and cloud-based offerings amid challenging global macroeconomic conditions.
Read moreThe final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Read more